River Head Capital appeared to be the VC, which was created in 2015. The fund was located in Asia if to be more exact in China. The leading representative office of defined VC is situated in the Chaoyang.
The fund has no specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight QingCloud, Suiyuan Technology, More Health. Among the most popular fund investment industries, there are Web Hosting, Cloud Computing. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the River Head Capital, startups are often financed by BlueRun Ventures, ZhenFund, Yunhe Partners. The meaningful sponsors for the fund in investment in the same round are Yunhe Partners, Tencent Holdings, Sky9 Capital. In the next rounds fund is usually obtained by Xiran Capital, China Pacific Insurance, CITIC Capital Holdings.
The typical startup value when the investment from River Head Capital is 500 millions - 1 billion dollars. Opposing the other organizations, this River Head Capital works on 9 percentage points less the average amount of lead investments. The fund is generally included in 2-6 deals every year. The high activity for fund was in 2019. Speaking about the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations. Deals in the range of 50 - 100 millions dollars are the general things for fund.
Fund Name | Location |
African Rainbow Capital | Gauteng, NA - South Africa, South Africa |
Arborview Capital | Chevy Chase, Maryland, United States |
FRONTIER Japan | Japan, Tokyo |
GP Investments | Bermuda, Hamilton |
Inter-Asia Venture Management | China, Hong Kong, Hong Kong Island |
Journey Growth | - |
MadDog Ventures | Birmingham, Michigan, United States |
Meruelo Capital Partners | California, Downey, United States |
Neva Finventures | Italy, Piemonte, Turin |
NHN Entertainment Corp | Kyonggi-do, Seongnam, South Korea |
Ocean Energy | - |
Plutus Capital | New York, New York, United States |
Sowefund | France, Ile-de-France, Paris |
Stripe | California, San Francisco, United States |
Synthetic Genomics | California, La Jolla, United States |
Tailwind Capital | New York, New York, United States |
The Growth Fund | Australia, New South Wales, Sydney |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Medical Source | $15M | 04 Aug 2023 | Kunshan, Anhui, China | ||
Bio-Engine | $46M | 15 May 2023 | Shanghai, China | ||
D2M Biotherapeutics | 03 Apr 2023 | - | |||
Sijie Microelectronics | 31 Jan 2023 | Shanghai, Shanghai, China | |||
Huzhou Shenke | 19 Jan 2023 | Hangzhou, Zhejiang, China | |||
Cell Probio | 15 Sep 2022 | Suzhou, Jiangsu, China | |||
WuXi Bo Rui | $44M | 02 Sep 2022 | Changping, Beijing, China | ||
Lepu Bio | $200M | 06 Aug 2020 | China, Shanghai | ||
AW Education International | $28M | 01 Jul 2020 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Medical Source | $15M | 04 Aug 2023 | Kunshan, Anhui, China | ||
Bio-Engine | $46M | 15 May 2023 | Shanghai, China | ||
D2M Biotherapeutics | 03 Apr 2023 | - | |||
Sijie Microelectronics | 31 Jan 2023 | Shanghai, Shanghai, China | |||
Huzhou Shenke | 19 Jan 2023 | Hangzhou, Zhejiang, China | |||
Cell Probio | 15 Sep 2022 | Suzhou, Jiangsu, China | |||
WuXi Bo Rui | $44M | 02 Sep 2022 | Changping, Beijing, China | ||
Lepu Bio | $200M | 06 Aug 2020 | China, Shanghai | ||
AW Education International | $28M | 01 Jul 2020 | Dongcheng District, Beijing, China |